0001493152-25-019187.txt : 20251024 0001493152-25-019187.hdr.sgml : 20251024 20251024084514 ACCESSION NUMBER: 0001493152-25-019187 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251024 DATE AS OF CHANGE: 20251024 EFFECTIVENESS DATE: 20251024 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akari Therapeutics Plc CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 981034922 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-561958 FILM NUMBER: 251414406 BUSINESS ADDRESS: STREET 1: 401 EAST JACKSON STREET STREET 2: SUITE 3300 CITY: TAMPA STATE: FL ZIP: 33602 BUSINESS PHONE: (929) 274-7510 MAIL ADDRESS: STREET 1: 401 EAST JACKSON STREET STREET 2: SUITE 3300 CITY: TAMPA STATE: FL ZIP: 33602 FORMER COMPANY: FORMER CONFORMED NAME: Celsus Therapeutics Plc. DATE OF NAME CHANGE: 20130621 FORMER COMPANY: FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC DATE OF NAME CHANGE: 20120201 D 1 primary_doc.xml X0708 D LIVE 0001541157 Akari Therapeutics Plc 401 EAST JACKSON STREET SUITE 3300 TAMPA FL FLORIDA 33602 (929) 274-7510 UNITED KINGDOM None Celsus Therapeutics Plc. Morria Biopharmaceuticals PLC Other Public Limited Company true Abizer Gaslightwala Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Executive Officer Director President and Chief Executive Officer Kameel Farag Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Executive Officer Interim Chief Financial Officer Rob Bazemore Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Hoyoung Huh Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Jim Neal Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Ray Prudo Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Samir Patel Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Sandip Patel Akari Therapeutics, Plc 401 East Jackson, Street Suite 3300 TAMPA FL FLORIDA 33602 Director Other Health Care Decline to Disclose 06b false 2025-10-16 false true true true American Depositary Shares (ADSs), each representing 2,000 Ordinary Shares false 0 Ladenburg Thalmann & Co. Inc. 000000505 None None 999 Vanderbilt Beach Road Suite 200 Naples FL FLORIDA 34108 CA CALIFORNIA CT CONNECTICUT FL FLORIDA IL ILLINOIS NY NEW YORK TX TEXAS true 6250000 6250000 0 Reflects proceeds from the exercise of 6,250,000 warrants (comprising 3,125,000 Series E and 3,125,000 Series F warrants, each with an ex. price of $0.98/ADS, and 125,000 placement agent warrants with an ex. price of $1.00/ADS). false 4 180000 0 Ladenburg Thalmann is also entitled to a mgmt. fee equal to 0.5% of the gross proceeds, reimbursement of up to $75,000, and 125,000 warrants to purchase ADSs exercisable at $1.00 per share for five years. 0 The Company intends to use the net proceeds for working capital, general corporate purposes, and continued research and development. false Akari Therapeutics Plc /s/ Abizer Gaslightwala Abizer Gaslightwala Chief Executive Officer and President 2025-10-24